An estimated 54,370 new cases of non-Hodgkin's lymphoma (NHL) will be diagnosed in 2004, and 19,410 individuals with NHL will die this year. NHL is the sixth leading site of new cancer cases among men and women, accounting for 4% of new cancer cases. NHL is also one of the few malignancies rising in incidence. The NHLs may be classified on the basis of morphology, natural history, and immunophenotypic and molecular characteristics. The National Comprehensive Cancer Network (NCCN) guidelines were developed for more common NHL histologic types and for less common entities with unique natural histories and therapies. This version of the guidelines incorporates the most significant changes to the guidelines since the initial publication.
For the most recent version of the guidelines, please visit NCCN.org
If the inline PDF is not rendering correctly, you can download the PDF file here.